InvesTrust
GSK icon

InvesTrust’s GSK GSK Stock Holding History

InvesTrust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.25M Sell
25,922
-3,048
-11% -$156K 0.51% 56
2026
Q2 		$1.52M Sell
28,970
-815
-3% -$43.1K 0.58% 54
2026
Q1 		$1.64M Sell
29,785
-238
-0.8% -$12.9K 0.69% 54
2025
Q4 		$1.47M Sell
30,023
-1,538
-5% -$71.7K 0.57% 53
2025
Q3 		$1.36M Buy
31,561
+44
+0.1% +$1.72K 0.5% 57
2025
Q2 		$1.21M Sell
31,517
-73,092
-70% -$2.79M 0.47% 59
2025
Q1 		$4.05M Buy
104,609
+3,311
+3% +$121K 1.11% 46
2024
Q4 		$3.42M Buy
+101,298
New +$3.65M 0.95% 46

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

InvesTrust's GSK Position: Q3 2026 in Review

InvesTrust reduced its GSK (GSK) stake by 11% in Q3 2026, selling an estimated $156K and leaving 25,922 shares worth $1.25M. The position accounts for 0.51% of the portfolio, ranked #56.

InvesTrust first reported a position in GSK in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.05M in Q1 2025. 418 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • InvesTrust held 25,922 shares of GSK worth $1.25M as of Q3 2026.
  • InvesTrust sold 3,048 GSK shares in Q3 2026, an estimated $156K.
  • GSK made up 0.51% of InvesTrust's portfolio in Q3 2026, its #56 holding.
  • InvesTrust first reported a position in GSK in Q4 2024 and has held it in 8 quarters since.
  • InvesTrust's GSK position peaked at $4.05M in Q1 2025.
  • 418 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on InvesTrust's 13F filing for Q3 2026, filed 14 Oct 2026.